C-reactive protein to albumin ratio: Is a new parameter for the disease severity in patients with psoriasis vulgaris?

dc.contributor.authorKemeriz, Funda
dc.contributor.authorTu?rul, Burcu
dc.contributor.authorTuncer, Sibel Çiğdem
dc.date.accessioned2021-06-16T09:41:08Z
dc.date.available2021-06-16T09:41:08Z
dc.date.issued2020
dc.departmentTıp Fakültesi
dc.description*Kemeriz, Funda ( Aksaray, Yazar ) *Tuncer, Sibel Çiğdem ( Aksaray, Yazar )
dc.description.abstractBackground: C-reactive protein to albumin ratio (CAR) is an inflammatory marker that is considered to have prognostic value in many inflammatory diseases. Objectives: In this study, we aimed to investigate whether there is a correlation between CAR value and disease severity in patients with psoriasis. Methods: The study included 70 plaque-type psoriasis patients and 67 healthy controls. CAR value was calculated after C-reactive protein (CRP) and albumin analysis was performed, Psoriasis Area and Severity Index (PASI) scores were documented. CAR value was compared with PASI scores in patient group. White blood cell count, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, erythrocyte sedimentation rate (ESR), and mean platelet volume and CAR values were compared among these groups. We investigated the most significant parameter for disease severity. In addition, to detect relationship between CAR, disease duration and patients' age and healthy controls, correlation analysis was performed. Results: The median CAR value was found statistically significant higher in the patient group than in the control group (P < 0.001). A significant difference of median CRP, albumin, CAR (all P values are <0.001) and ESR (P = 0.024) were found among the three groups which were arranged according to the severity of the disease. Among these parameters, CAR was found as the most associated parameter with the severity of psoriasis using receiving operator characteristic analysis. Conclusion: CAR value could be a useful parameter for evaluating disease severity, management of disease activity, and follow-up strategies.
dc.identifier.doi10.4103/ds.ds_42_20
dc.identifier.endpage204en_US
dc.identifier.issn1027-8117
dc.identifier.issue4en_US
dc.identifier.scopusqualityQ2
dc.identifier.startpage199en_US
dc.identifier.urihttps:/dx.doi.org/10.4103/ds.ds_42_20
dc.identifier.urihttps://hdl.handle.net/20.500.12451/8117
dc.identifier.volume38en_US
dc.identifier.wosWOS:000601216500001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.ispartofDermatologica Sinica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAlbumin
dc.subjectC-reactive Protein
dc.subjectC-reactive Protein to Albumin Ratio
dc.subjectDisease Severity
dc.subjectPsoriasis
dc.titleC-reactive protein to albumin ratio: Is a new parameter for the disease severity in patients with psoriasis vulgaris?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
kemeriz-funda-2020.pdf
Boyut:
593.33 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: